Last update 04 Nov 2024
HiFiBiO Therapeutics (Hangzhou) Co., Ltd.
Last update 04 Nov 2024
Overview
Tags
Neoplasms
Monoclonal antibody
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
一项HFB200301（TNFR2激动剂抗体）单药治疗以及与替雷利珠单抗（抗PD-1抗体）联合用药治疗成人晚期实体瘤患者的Ia/Ib期、开放性、多中心、剂量递增和剂量扩展研究
[Translation] A Phase Ia/Ib, open-label, multicenter, dose-escalation and dose-expansion study of HFB200301 (TNFR2 agonist antibody) as monotherapy and in combination with tislelizumab (anti-PD-1 antibody) in adult patients with advanced solid tumors
100 Clinical Results associated with HiFiBiO Therapeutics (Hangzhou) Co., Ltd.
Login to view more data
Login to view more data
11 Jun 2021Science advancesQ1 · CROSS-FIELD
High-throughput functional screening for next-generation cancer immunotherapy using droplet-based microfluidics
Q1 · CROSS-FIELD
ArticleOA
Author: Fang, Pan ; Zhang, Hongkai ; Schweizer, Liang ; Wang, Shanshan ; Mary, Pascaline ; Wang, Yuan ; Zhao, Yingjie ; Tian, Yujie ; Shen, Bingqing ; Zhou, He ; Jin, Ruina ; Li, Na ; Li, Fubin ; Huang, Mengshi ; Ma, Peixiang ; Wang, Wei ; Li, Ruonan ; Cao, Youjia ; Wang, Ruikun
Microfluidics system enables high-throughput functional screening of antibodies for cancer immunotherapy.
100 Deals associated with HiFiBiO Therapeutics (Hangzhou) Co., Ltd.
Login to view more data
100 Translational Medicine associated with HiFiBiO Therapeutics (Hangzhou) Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 24 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free